<?xml version="1.0" encoding="UTF-8"?>
<ref id="B44-viruses-12-00904">
 <label>44.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Roels</surname>
    <given-names>G.L.</given-names>
   </name>
   <name>
    <surname>Cramer</surname>
    <given-names>J.P.</given-names>
   </name>
   <name>
    <surname>Mendelman</surname>
    <given-names>P.M.</given-names>
   </name>
   <name>
    <surname>Sherwood</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Clemens</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Aerssens</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Damme</surname>
    <given-names>P.V.</given-names>
   </name>
  </person-group>
  <article-title>Safety and immunogenicity of different formulations of norovirus vaccine candidate in healthy adults: A randomized, controlled, double-blind clinical trial</article-title>
  <source>J. Infect. Dis.</source>
  <year>2018</year>
  <volume>217</volume>
  <fpage>597</fpage>
  <lpage>607</lpage>
  <pub-id pub-id-type="doi">10.1093/infdis/jix572</pub-id>
  <?supplied-pmid 29140444?>
  <pub-id pub-id-type="pmid">29140444</pub-id>
 </element-citation>
</ref>
